Jade Biosciences, Inc.
Assets & Liabilities
| Period | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| Mar 2022 | $5.1M | $167.0M | $28.1M |
| Jun 2022 | $4.6M | $155.7M | $27.5M |
| Sep 2022 | $8.5M | $147.7M | $22.4M |
| Dec 2022 | $8.6M | $135.3M | $22.4M |
| Mar 2023 | $11.3M | $124.4M | $26.6M |
| Jun 2023 | $13.8M | $155.8M | $60.9M |
| Sep 2023 | $15.2M | $140.9M | $32.2M |
| Dec 2023 | $18.0M | $127.4M | $23.5M |
| Mar 2024 | $15.9M | $106.8M | $9.1M |
| Jun 2024 | $17.3M | $111.7M | $31.1M |
| Sep 2024 | $10.5M | $91.0M | $31.1M |
| Dec 2024 | $119.6M | $72.8M | $69.4M |
| Mar 2025 | $2.5M | $77.5M | $44.2M |
| Jun 2025 | $22.4M | $224.0M | $220.9M |
| Sep 2025 | $23.1M | $202.5M | $50.1M |
| Dec 2025 | $17.3M | $349.8M | $88.4M |
| Mar 2026 | $23.0M | $319.4M | $55.1M |
| Jun 2026 | $32.2M | $472.1M | $107.3M |